SCG
NVS icon

Sonata Capital Group’s Novartis NVS Stock Holding History

Sonata Capital Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,453
Closed -$202K – 100
2015
Q3 		$202K Hold
2,453
– – 0.19% 91
2015
Q2 		$216K Hold
2,453
– – 0.19% 93
2015
Q1 		$217K Buy
+2,453
New +$218K 0.19% 92

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Sonata Capital Group's NVS Position: Q4 2015 in Review

Sonata Capital Group sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,453 shares — an estimated $202K sold.

Sonata Capital Group first reported a position in NVS in Q1 2015 and held it in 3 quarters. The position peaked at $217K in Q1 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • Sonata Capital Group reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • Sonata Capital Group sold 2,453 Novartis shares in Q4 2015, an estimated $202K.
  • Sonata Capital Group first reported a position in Novartis in Q1 2015 and held it in 3 quarters.
  • Sonata Capital Group's Novartis position peaked at $217K in Q1 2015.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Sonata Capital Group's 13F filing for Q4 2015, filed 2 Feb 2016.